Home/Filings/4/0000950170-24-116783
4//SEC Filing

Kush Arvind 4

Accession 0000950170-24-116783

CIK 0001750149other

Filed

Oct 22, 8:00 PM ET

Accepted

Oct 23, 7:49 PM ET

Size

6.6 KB

Accession

0000950170-24-116783

Insider Transaction Report

Form 4
Period: 2024-10-21
Kush Arvind
Director
Transactions
  • Purchase

    Common Stock

    2024-10-21$1.37/sh+145,000$198,650145,000 total
  • Award

    Stock Option (right to buy)

    2024-10-21+60,00060,000 total
    Exercise: $2.22Exp: 2034-10-21Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The option shares vest 50% on each of the first two anniversaries of October 21, 2024.

Documents

1 file

Issuer

Inhibikase Therapeutics, Inc.

CIK 0001750149

Entity typeother

Related Parties

1
  • filerCIK 0001986806

Filing Metadata

Form type
4
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 7:49 PM ET
Size
6.6 KB